In consequence, the crosstalk element mTOR which regulates ALP to degrade the aggregation of αSyn* may become one of the most crucial targets for the treatment of PD (Ebrahimi-Fakhari et al., 2014; Lan et al., 2017). Here, MTOR is linked to Parkinson disease.